Wenjia Li

Director Business Development at Roche

Presenter

Roche is a leading healthcare company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2023 employed over 100,000 people worldwide. To revolutionise healthcare, Roche is investing heavily in research and development with CHF 14 billion in 2023 and posted sales of CHF 58.7. billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. Our Pharma Partnering team provides comprehensive business development and alliance management support for Roche and Genentech's R&D units and the broader pharmaceutical division. Alongside the broad internal pipeline, external innovation has always been a critical component of our R&D strategy. In 2023, we entered into more than 70 new partnerships and are managing over 250 ongoing alliances worldwide.